Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2174/1570159X13666150630171954 http://scihub22266oqcxt.onion/10.2174/1570159X13666150630171954 C4761631!4761631!26467409     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=26467409&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Curr+Neuropharmacol 2015 ; 13 (5): 592-604 Nephropedia Template TP {{tp|p=26467409|t=2015. Pharmacological Approaches for Treatment-resistant Bipolar Disorder |pdf=|usr=}}{{26467409}} gab.com Text Pharmacological Approaches for Treatment-resistant Bipolar Disorder JO: Curr Neuropharmacol http://www.kidney.de/pget.php?&tw=1&pmid=26467409 #FOAvip Bipolar disorder is prevalent, with high risks of disability, substance abuse and premature mortality. Treatment responses typically are incomplete, especially for depressive components, so that many cases can be considered ?treatment resistant.? We reviewed reports on experimental treatments for such patients: there is a striking paucity of such research, mainly involving small incompletely controlled trials of add-on treatment, and findings remain preliminary. Encouraging results have been reported by adding aripiprazole, bupropion, clozapine, ketamine, memantine, pramipexole, pregabalin, and perhaps tri-iodothyronine in resistant manic or depressive phases. The urgency of incomplete responses in such a severe illness underscores the need for more systematic, simpler, and better controlled studies in more homogeneous samples of patients. Twit Text FOAVip Pharmacological Approaches for Treatment-resistant Bipolar Disorder ????Curr Neuropharmacol http://www.kidney.de/pget.php?&tw=1&pmid=26467409 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26467409 #FOAvip English Wikipedia <ref>{{Cite pmid|26467409}}</ref> Pharmacological Approaches for Treatment-resistant Bipolar Disorder #MMPMID26467409 Poon SH; Sim K; Baldessarini RJ Curr Neuropharmacol 2015[Sep]; 13 (5): 592-604 PMID26467409show ga Bipolar disorder is prevalent, with high risks of disability, substance abuse and premature mortality. Treatment responses typically are incomplete, especially for depressive components, so that many cases can be considered ?treatment resistant.? We reviewed reports on experimental treatments for such patients: there is a striking paucity of such research, mainly involving small incompletely controlled trials of add-on treatment, and findings remain preliminary. Encouraging results have been reported by adding aripiprazole, bupropion, clozapine, ketamine, memantine, pramipexole, pregabalin, and perhaps tri-iodothyronine in resistant manic or depressive phases. The urgency of incomplete responses in such a severe illness underscores the need for more systematic, simpler, and better controlled studies in more homogeneous samples of patients. äPharmacological Approaches for Treatment-resistant Bipolar Disorder (epmc).pdf DeepDyve Pubget Overpricing